| Research priorities | |
|---|---|
|
| |
| 8.1 | Identify surrogate markers (biomarkers, imaging) that would assist in understanding the possible mechanisms of action of gene- and cell-based therapies in CLTI. |
| 8.2 | Determine whether gene- or cell-based therapies can serve as an adjunct to revascularization to improve clinical outcomes in subsets of CLTI patients. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.